On Invalid Date, Morphic Holding (NASDAQ: MORF) reported Q4 2023 earnings per share (EPS) of -$0.94, up 46.88% year over year. Total Morphic Holding earnings for the quarter were -$40.74 million. In the same quarter last year, Morphic Holding's earnings per share (EPS) was -$0.64.
As of Q2 2024, Morphic Holding's earnings has grown year over year. Morphic Holding's earnings in the past year totalled -$152.10 million.
What was MORF's revenue last quarter?
On Invalid Date, Morphic Holding (NASDAQ: MORF) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Morphic Holding's revenue was $6.14 million.
What was MORF's revenue growth in the past year?
As of Q2 2024, Morphic Holding's revenue has grown -99.26% year over year. This is 248.56 percentage points lower than the US Biotechnology industry revenue growth rate of 149.3%. Morphic Holding's revenue in the past year totalled $521.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.